Background: This study aims to explore the clinical utility of Evolocumab in combination with an e-Health System: Swiss Prospective Observational Study in Patients with clinical Atherosclerotic Cardiovascular Disease. Sponsor: Amgen, Switzerland Trial Status: recruiting Enrolling Centers: Switzerland Core Study Team:

ECARA